Psychopharmacologic management of serious behavioral disturbance in ASD.Child Adolesc Psychiatr Clin N Am. 2014 Jan; 23(1):73-82.CA
Abstract
Individuals diagnosed with autism spectrum disorders (ASD) often exhibit serious behavioral disturbance (irritability) including severe tantrums, aggression, and self-injury that requires pharmacologic management. Research focused on the treatment of severe irritability has primarily involved the atypical antipsychotics, including risperidone and aripiprazole. Anticonvulsants have also been investigated for targeting serious behavioral disturbance; however findings have been mixed. Advances in the pharmacotherapy of irritability in ASD continue to inform practice. Research is needed to develop safer and more effective drug treatments for serious behavioral disturbance in this population.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Language
eng
PubMed ID
24231168
Citation
Stigler, Kimberly A.. "Psychopharmacologic Management of Serious Behavioral Disturbance in ASD." Child and Adolescent Psychiatric Clinics of North America, vol. 23, no. 1, 2014, pp. 73-82.
Stigler KA. Psychopharmacologic management of serious behavioral disturbance in ASD. Child Adolesc Psychiatr Clin N Am. 2014;23(1):73-82.
Stigler, K. A. (2014). Psychopharmacologic management of serious behavioral disturbance in ASD. Child and Adolescent Psychiatric Clinics of North America, 23(1), 73-82. https://doi.org/10.1016/j.chc.2013.07.005
Stigler KA. Psychopharmacologic Management of Serious Behavioral Disturbance in ASD. Child Adolesc Psychiatr Clin N Am. 2014;23(1):73-82. PubMed PMID: 24231168.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Psychopharmacologic management of serious behavioral disturbance in ASD.
A1 - Stigler,Kimberly A,
Y1 - 2013/09/14/
PY - 2013/11/16/entrez
PY - 2013/11/16/pubmed
PY - 2014/6/24/medline
KW - Aggression
KW - Autism
KW - Autism spectrum disorders
KW - Irritability
KW - Psychopharmacology
KW - Self-injury
SP - 73
EP - 82
JF - Child and adolescent psychiatric clinics of North America
JO - Child Adolesc Psychiatr Clin N Am
VL - 23
IS - 1
N2 - Individuals diagnosed with autism spectrum disorders (ASD) often exhibit serious behavioral disturbance (irritability) including severe tantrums, aggression, and self-injury that requires pharmacologic management. Research focused on the treatment of severe irritability has primarily involved the atypical antipsychotics, including risperidone and aripiprazole. Anticonvulsants have also been investigated for targeting serious behavioral disturbance; however findings have been mixed. Advances in the pharmacotherapy of irritability in ASD continue to inform practice. Research is needed to develop safer and more effective drug treatments for serious behavioral disturbance in this population.
SN - 1558-0490
UR - https://www.unboundmedicine.com/medline/citation/24231168/Psychopharmacologic_management_of_serious_behavioral_disturbance_in_ASD_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S1056-4993(13)00061-8
DB - PRIME
DP - Unbound Medicine
ER -